NCT06311617 Retinal Vascular Changes During Pregnancy
| NCT ID | NCT06311617 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University Medical Center |
| Condition | Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2024-02-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and after delivery. This imaging is non-invasive and does not require contact with the surface of the eye. The photos taken will allow assessment of specific parameters, like blood flow and the health of specialized cells that support vision. Understanding how the eyes change during pregnancy may help guide how retina specialists understanding of retinal disease during pregnancy and better inform pregnancy outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Patient age 18 years and older 2. Patient able to provide informed consent 3. Pregnant at time of enrollment and in the 1st or 2nd trimester of pregnancy Exclusion Criteria: 1. Other ocular disease that prevents imaging (significant cataract or other media opacity) 2. Unable to comply with imaging or follow-up through duration of study
Contact & Investigator
Avni P Finn, MD, MBA
PRINCIPAL INVESTIGATOR
Vanderbilt Eye Institute
Frequently Asked Questions
Who can join the NCT06311617 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06311617 currently recruiting?
Yes, NCT06311617 is actively recruiting participants. Contact the research team at saige.priddy@vumc.org for enrollment information.
Where is the NCT06311617 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT06311617 clinical trial?
NCT06311617 is sponsored by Vanderbilt University Medical Center. The principal investigator is Avni P Finn, MD, MBA at Vanderbilt Eye Institute. The trial plans to enroll 90 participants.